Allergy and Immunology

  1. SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

    1. Angelika Wagner
    2. Erika Garner-Spitzer
    3. Anna-Margarita Schötta
    4. Maria Orola
    5. Andrea Wessely
    6. Ines Zwazl
    7. Anna Ohradanova-Repic
    8. Lukas Weseslindtner
    9. Gabor Tajti
    10. Laura Gebetsberger
    11. Bernhard Kratzer
    12. Elena Tomosel
    13. Maximilian Kutschera
    14. Selma Tobudic
    15. Winfried F. Pickl
    16. Michael Kundi
    17. Hannes Stockinger
    18. Gottfried Novacek
    19. Walter Reinisch
    20. Christoph Zielinski
    21. Ursula Wiedermann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

    1. Kaori Sano
    2. Disha Bhavsar
    3. Gagandeep Singh
    4. Daniel Floda
    5. Komal Srivastava
    6. Charles Gleason
    7. PARIS Study Group
    8. Angela A. Amoako
    9. Dalles Andre
    10. Katherine F. Beach
    11. Maria C. Bermúdez-González
    12. Gianna Cai
    13. Christian Cognigni
    14. Hisaaki Kawabata
    15. Giulio Kleiner
    16. Neko Lyttle
    17. Wanni Mendez
    18. Lubbertus C. F. Mulder
    19. Annika Oostenink
    20. Ariel Raskin
    21. Aria Rooker
    22. Kayla T. Russo
    23. Ashley Beathrese T. Salimbangon
    24. Miti Saksena
    25. Levy A. Sominsky
    26. Johnstone Tcheou
    27. Ania Wajnberg
    28. Juan Manuel Carreño
    29. Viviana Simon
    30. Florian Krammer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Comparison of in-hospital COVID-19 related outcomes between COVISHIELD and COVAXIN recipients

    1. Tejas M. Suri
    2. Tamoghna Ghosh
    3. M Arunachalam
    4. Rohit Vadala
    5. Saurabh Vig
    6. Sushma Bhatnagar
    7. Anant Mohan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients

    1. Dinesh Mohanraj
    2. Samuel Baldwin
    3. Satbeer Singh
    4. Alun Gordon
    5. Alison Whitelegg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

    1. Sitthichai Kanokudom
    2. Suvichada Assawakosri
    3. Nungruthai Suntronwong
    4. Chompoonut Auphimai
    5. Pornjarim Nilyanimit
    6. Preeyaporn Vichaiwattana
    7. Thanunrat Thongmee
    8. Ritthideach Yorsaeng
    9. Donchida Srimuan
    10. Thaksaporn Thatsanatorn
    11. Sirapa Klinfueng
    12. Natthinee Sudhinaraset
    13. Nasamon Wanlapakorn
    14. Sittisak Honsawek
    15. Yong Poovorawan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination

    1. Blair Armistead
    2. Yonghou Jiang
    3. Marc Carlson
    4. Emily S. Ford
    5. Saumya Jani
    6. John Houck
    7. Xia Wu
    8. Lichen Jing
    9. Tiffany Pecor
    10. Alisa Kachikis
    11. Winnie Yeung
    12. Tina Nguyen
    13. Rene Coig
    14. Nana Minkah
    15. Sasha E. Larsen
    16. Rhea N. Coler
    17. David M. Koelle
    18. Whitney E. Harrington

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation

    1. Rachel E. Lamerton
    2. Edith Marcial-Juarez
    3. Sian E. Faustini
    4. Marisol Perez-Toledo
    5. Margaret Goodall
    6. Siân E. Jossi
    7. Maddy L. Newby
    8. Iain Chapple
    9. Thomas Dietrich
    10. Tonny Veenith
    11. Adrian M. Shields
    12. Lorraine Harper
    13. Ian R. Henderson
    14. Julie Rayes
    15. David C. Wraith
    16. Steve P. Watson
    17. Max Crispin
    18. Mark T. Drayson
    19. Alex G. Richter
    20. Adam F. Cunningham

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine

    1. Nasamon Wanlapakorn
    2. Ritthideach Yorsaeng
    3. Harit Phowatthanasathian
    4. Nungruthai Suntronwong
    5. Sitthichai Kanokudom
    6. Natthinee Sudhinaraset
    7. Yong Poovorawan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen

    1. Yuan Li
    2. Xin Fang
    3. Rongjuan Pei
    4. Renfeng Fan
    5. Shaomin Chen
    6. Peiyu Zeng
    7. Zhiqiang Ou
    8. Jinglong Deng
    9. Jian Zhou
    10. Zehui Sun
    11. Lishi Liu
    12. Hua Peng
    13. Xujia Chen
    14. Zhipeng Su
    15. Xi Chen
    16. Jianfeng He
    17. Wuxiang Guan
    18. Zhongyu Hu
    19. Yang-Xin Fu
    20. Jikai Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

    1. Nasamon Wanlapakorn
    2. Nungruthai Suntronwong
    3. Harit Phowatthanasathian
    4. Ritthideach Yorsaeng
    5. Preeyaporn Vichaiwattana
    6. Thanunrat Thongmee
    7. Chompoonut Auphimai
    8. Donchida Srimuan
    9. Thaksaporn Thatsanatorn
    10. Suvichada Assawakosri
    11. Sitthichai Kanokudom
    12. Yong Poovorawan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 10 of 24 Next